Los péptidos natriuréticos en el diagnóstico de la insuficiencia cardíaca en atención primaria / The natriuretic peptides in the diagnosis of heart failure in primary care setting

La insuficiencia cardíaca (IC) es un síndrome clínico que se caracteriza por síntomas y signos causados por anomalías estructurales y/o funcionales del corazón que provocan una reducción en el gasto cardíaco y/o elevación de las presiones intracardíacas en reposo o durante el ejercicio. Su prevalencia y su incidencia están aumentando y constituye la primera causa de hospitalización en mayores de 65años. Las nuevas guías europeas y americanas para el manejo de la IC destacan que la medición de las concentraciones de péptidos natriuréticos (PN) constituye una piedra angular del manejo diagnóstico de la IC, y que la anamnesis, la exploración física, el electrocardiograma y la radiografía de tórax completan el inicio del proceso diagnóstico de la IC. Todas estas acciones y pruebas diagnósticas son susceptibles de realizarlas y solicitarlas desde la consulta del médico de familia. Los autores del presente documento, en nombre del Grupo de Trabajo de Hipertensión Arterial y Enfermedad Cardiovascular de SEMERGEN, han revisado la evidencia científica más reciente relacionada con el manejo diagnóstico de los PN en los pacientes con IC en el ámbito de la atención primaria (AU)

Heart failure (HF) is a clinical syndrome characterized by symptoms and signs caused by structural and/or functional abnormalities of the heart that cause reduced cardiac output and/or elevated intracardiac pressures at rest or during exercise. Its prevalence and incidence are increasing and it is the leading cause of hospitalization in people over 65years of age. The new American and European guidelines for the management of HF emphasize that the measurement of natriuretic peptide (NP) concentrations constitutes a cornerstone of the diagnostic management of HF, and that the history, physical examination, electrocardiogram, and chest X-ray, complete the beginning of the HF diagnostic process. All these actions and diagnostic tests can be performed and requested from the primary care office. The authors of this document, on behalf of the SEMERGEN Hypertension and Cardiovascular Disease Working Group, have reviewed the most recent scientific evidence related to the preventive diagnostic management of NP in patients with HF in primary care setting (AU)

[The natriuretic peptides in the diagnosis of heart failure in primary care setting]. / Los péptidos natriuréticos en el diagnóstico de la insuficiencia cardíaca en atención primaria.

Heart failure (HF) is a clinical syndrome characterized by symptoms and signs caused by structural and/or functional abnormalities of the heart that cause reduced cardiac output and/or elevated intracardiac pressures at rest or during exercise. Its prevalence and incidence are increasing and it is the leading cause of hospitalization in people over 65years of age. The new American and European guidelines for the management of HF emphasize that the measurement of natriuretic peptide (NP) concentrations constitutes a cornerstone of the diagnostic management of HF, and that the history, physical examination, electrocardiogram, and chest X-ray, complete the beginning of the HF diagnostic process. All these actions and diagnostic tests can be performed and requested from the primary care office. The authors of this document, on behalf of the SEMERGEN Hypertension and Cardiovascular Disease Working Group, have reviewed the most recent scientific evidence related to the preventive diagnostic management of NP in patients with HF in primary care setting.